Since 1984, the Radiological Physics Center~RPC! has used the American Association of Physicists in Medicine Task Group 21~TG-21! protocol~absorbed dose determination! as the basis of its On-site Dosimetry Review visits to institutions participating in the National Cancer Institute's cooperative clinical trials. Subsequent to the TG-21 protocol, the Task Group 25~TG-25! report on electron-beam dosimetry was published. The TG-25 report was not intended to supercede the TG-21 protocol, but to supplement it for depths other than d max . However, both reports included measurement techniques and data regarding the calibration of electron beams. TG-25 was not intended for absolute calibrations made clear by the fact that it does not present all of the data required for plastic phantom calibrations, i.e., unrestricted stopping power ratios. As a result, some confusion has arisen at various institutions as to which protocol should be used for machine calibration. In this study, possible discrepancies that arise when using TG-21, a version of TG-21 modified by the RPC, and TG-25 are compared. The differences in the results are calculated as a function of energy~6 and 20 MeV!, chamber type~cylindrical or parallel plate!, and the type of phantom material~water, polystyrene, or acrylic!. The largest discrepancies noted were between TG-25 and the two TG-21 methods for low-energy electrons in either water or polystyrene. The mean difference for all conditions was 0.8% with a maximum value of 3.3% in polystyrene. The definition of the effective point of measurement; determination of the mean nominal incident energy (Ē 0 ), mean energy at depth (Ē z ), and most probable energy at the surface (E p,0 ) for each protocol, and subsequent stopping power ratio, chamber replacement factor, and electron fluence correction factor are the major contributors to the calculated differences. © 1997 American Association of Physicists in Medicine. @S0094-2405~97!00607-X#
I. INTRODUCTION
Since 1969, the Radiological Physics Center~RPC! has been performing On-Site Dosimetry Review visits to institutions participating in cooperative clinical trials funded by the National Cancer Institute. A key part of each review visit is the independent determination of the absorbed dose output~cGy per monitor unit! for each high-energy photon and electron beam, the so-called ''calibration'' or ''output verification.'' It is RPC policy to implement established dosimetry protocols. In 1983, the American Association of Physicists in Medicine~AAPM! Task Group 21~TG-21! 1 published a protocol for calibration of photon and electron beams. This document provides techniques and data for determining the absorbed dose rate for high-energy photon and electron beams. The procedure involves two steps:~1! determining the dose to gas in the chamber cavity, and~2! calculating the dose to water, using the Bragg-Gray Cavity Theory. 2, 3 The TG-21 protocol is the accepted calibration protocol in North America. Since April 1984, the RPC has used TG-21 as the basis for absorbed dose rate calculations during their review visits. The RPC has deviated from the TG-21 protocol in only one respect. The RPC uses a 2 mm shift to the effective point of measurement depth for all depths for electron calibrations, whereas, the TG-21 protocol does not mention the need to determine the effective point of measurement at d max , the calibration depth, although a shift is recommended for the d 50 and R p measurements.
Subsequent to the publication of the TG-21 protocol, the AAPM Task Group 25 published a report entitled ''Clinical electron-beam dosimetry: Report of AAPM Radiation Therapy Committee Task Group No. 25~TG-25!.'' 4 This report includes measurement techniques, procedures on how to gather the data necessary for treatment planning and acceptance testing of linear accelerators, and instructions for using the dosimetry data to calculate beam-on time. Although the TG-25 report was specifically not intended to supercede the TG-21 protocol, both methods include measurement techniques and data regarding the determination of the absorbed dose rate under reference conditions for electron beams. As a result, some institutions are confused as to which method should be used for machine calibration. The TG-25 report provides recommendations for the measurement of the dose relative to the calibration dose, not the absolute determination of the absorbed dose. The TG-25 report recommends that the TG-21 protocol, the Hospital Physicists Association~HPA! protocol, 5 or other modem ''calibration'' protocol be used to determine absorbed dose rate. In spite of this recommendation, to determine absorbed dose rate the RPC has noted during their review visits that some physicists use the TG-25 report as a calibration protocol. The purpose of this paper is two-fold:~1! to indicate specific differences in the data and techniques between TG-21 and TG-25; and~2! to show the magnitude of the discrepancies in results when following the TG-21 protocol strictly, the RPC-modified TG-21 version~TG-21m!, or the TG-25 report. The discrepancies are calculated as a function of electron energy, chamber type, and phantom material.
II. METHODS
The calculations in this study were based on an NEL 2571 Nuclear Enterprises, Ltd., Fairfield, NJ! farmer-type cylindrical ion chamber with a graphite thimble with an inner diameter of 0.63 cm or a Memorial Parallel Plate chamber MPPK!~Victoreen, Inc./Nuclear Associates, Cleveland, OH!. Phantoms of water, polystyrene, and acrylic large enough to provide full scatter conditions were assumed. Calculations were made for 6 and 20 MeV electron beams on a Varian Clinac 2100C~Varian Associates, Inc., Palo Alto, CA!. It was determined that these electron energies would yield results representative of the limits expected in a clinical environment. The results obtained with the three methods were compared.
The following equation was used to calculate absorbed dose in each method:
where Dϭabsorbed dose~cGy per monitor unit!.
The factors in the calculation of absorbed dose that differ with each protocol are the chamber replacement factor ( P repl ), the mean restricted collision stopping power ratio (L/r), and the electron fluence correction factor~f!. Because our findings are presented as ratios, i.e., D TG-25 /D TG-21 , or D TG-21m /D TG-21 , the other factors in the equation cancel each other. All of the data presented here are calculational and do not include any measurements.
The practical range for each electron beam was calculated using an empirical relationship derived from the RPC measured practical range (R p ) data versus the depth of 50% ionization data determined for Varian Clinacs~data not yet published!. The empirical equation seen below was derived in the same way Kirby et al. 6 did, but with more recent data for modern Clinacs,
where d 50 ϭdepth of 50% ionization in mm.
All phantom material physical densities and scaling factors used were those listed in the TG-21 protocol.
III. RESULTS AND DISCUSSION
Tables I and II list the variables and factors used to calculate the potential discrepancies between D TG-21 , D TG-21m , and D TG-25 for the cylindrical chamber and the parallel plate chamber, respectively. The first item to note is the depth. For the cylindrical chamber, we list both a physical and an effective depth. In the plastic phantoms, the depths were scaled appropriately using the scaling factors in the TG-21 protocol. TG-21 discusses the need for a shift to the effective point of measurement for cylindrical chambers and actually lists a value of 0.75r~r is the inner radius of the sensitive volume of the ion chamber!. The TG-21 protocol recommends applying the shift correction to determine the depth of 50% ionization and practical range, but makes no recommendation as to the effective point of measurement at d max . TG-25, on the other hand, recommends for cylindrical chambers that a shift of 0.5r upstream be applied at all depths and energies. For the NEL 2571 ion chamber, the shift to the effective point of measurement for d 50 is 2.4, 2.0, and 1.6 mm according to the TG-21, TG-21m, and TG-25 methods, respectively. The 2 mm shift applied by the TG21m is a compromise between ease of use and the precise 0.75r of the TG-21 protocol. When the TG-25 report recommended the shift be 0.5r, the RPC continued using the 2 mm shift, which lies directly between the 0.75r and 0.5r of the TG-21 and TG-25 protocols, respectively. Both protocols agree that for a parallel plate chamber, the effective point of measurement is the front surface of the collection volume of the chamber. Therefore, in Table II , for the parallel plate chamber, there are no differences among the three techniques for determining d 50 or d max in each phantom material. Similarly, the R p has various values for the various energy and phantom combinations.
The nominal incident energy (Ē 0 ) for each electron beam depends on the depth of 50% ionization. TG-21 and TG-25 recommend the following equation to determine Ē 0 in water. The proper scaling factors must be included if polystyrene or acrylic phantoms are used, Ē 0 ϭ~C !~d 50 !~scaling factor!.~2! According to the TG-21 protocol, C equals 2.33 for all electron energies. The TG-25 protocol recommends that the TG-21 or HPA formalism values of C be used but states that if a more accurate value of Ē 0 is desired, the new data published in TG-25 should be used. A plot of C is provided in the TG-25 protocol as a function of the depth of 50% dose that varies from 2.37 to 2.7. As a result of the different C values and the shifts in the effective points of measurement, the Ē 0 listed in Tables I and II differ for each of the three methods for cylindrical and parallel plate chambers, respectively. This is significant because a series of other factors used to calculate the absorbed dose rate depend on Ē 0 . These factors, listed in Tables I and II , include Ē z , P repl , and L/r.
Even though Ē z differs by as much as 24% at 6 MeV for the cylindrical chambers, P repl remains essentially unchanged~within 0.2%! for all three methods, electron energies, and phantom materials. The P repl for the MPPK chamber is assumed to be 1.00. The mean restricted stopping power, L/r, is quite sensitive to a change in Ē 0 and the depth of calibration. The value of L/r can differ by as much as 2.2% among techniques for low-energy electrons calibrated in any of three phantom materials for the cylindrical chamber, as seen in Table I . The L/r values for the parallel plate chamber can differ by as much as 2.0% among the three techniques for the low energy electrons.
When the absorbed dose rate is determined in a plastic phantom, f must be incorporated into the calculation. This factor depends on the phantom material, electron energy, and the depth of calibration. The TG-21 protocol, however, provides an oversimplication of the fluence correction by reducing a two-parameter factor dependent on energy and depth down to a single-parameter correction factor dependent only on energy, Ē 0 , introducing some degree of error. The TG-25 report contains correction factors as a function of depth and energy for both polystyrene and acrylic. The electron energy used by the TG-25 report is the most probable kinetic energy at the surface (E p,0 ), not Ē 0 . The TG-25 report provides a simple relationship to calculate E p,0 as a function of (R p ) of the electrons in water. The equation for E p,0 in TG-25 is
The differences in the determination of f, outlined above, introduce an approximate 1% difference in f for low-energy electrons in polystyrene for both chamber types. If the calibration is performed in acrylic, there is also a 1% difference in f for low-energy electrons, but in the opposite direction. This occurs because the TG-21 protocol does not provide f values for acrylic. As seen in Tables I and II for the 20 MeV electrons, there is no significant difference in f between the TG-21 protocol and TG-25 report. The RPC routinely performs calibrations in water, and therefore, no f is required. However, when the RPC does calibrate in a polystyrene plastic phantom with the MPPK chamber, the f values found in the TG-21 protocol are used. Table III summarizes the results of Tables I and II . The product of L/r, P repl , and f is directly proportional to the dose at the calibration depth. Therefore, the ratio of these products between TG-21, TG-21m, and TG-25 represent the ratio of the dose determined by the various protocols. The largest difference noted for the 20 MeV beam was 1% in an acrylic phantom between TG-21 and TG-25. For calibration in acrylic, the differences noted for L/r and P repl between the three calibration methods are canceled by the fact that TG-25 incorporates f and TG-21 does not. Therefore, the resulting products for the acrylic absorbed dose calculations for the three methods are all within 1.0%. The most significant differences between the three methods are noted for low-energy electrons~6 MeV! calibrated in water and polystyrene. For the cylindrical chamber, the disagreements between TG-21 and TG-25 can be as much as 1.7% and 3.3% for water and polystyrene, respectively. A difference of 1.5% between TG-21 and TG-25 is also noted for the parallel plate chamber in polystyrene for the 6 MeV beam. For the other energy/phantom combinations, the TG-21 and TG-21m techniques agree well with TG-25~within 0.5%! for the parallel plate chamber. The RPC modifications of the TG-21 protocol, the shift to the effective point of measurements at d max , results in dose calculations that are approximately 1% lower than TG-21 at 6 MeV, but in closer agreement at 20 MeV, which results in a smaller discrepancy between TG21m and TG-25 than between TG-21 and TG-25.
IV. CONCLUSIONS
We have demonstrated that the absorbed dose rate for electron beams differs depending on the method used in its calculation. The three techniques analyzed here are TG-21, TG21m, and TG-25. The major differences were noted for the low-energy electron beams in either water or polystyrene between TG-25 and the two TG-21 methods for both chamber types. The significant contributors to these differences were the definition of the effective point of measurement; determination of Ē 0 , Ē z , and E p,0 for each method; and subsequent L/r, P repl , and f values for both chamber types. The maximum differences of 2%-3% were noted between the TG-21 and TG-25 at 6 MeV for a cylindrical chamber. Although the maximum differences may have limited clinical significance, it is important to preserve as much consistency as possible. Therefore, we recommend that~1! physicists heed the recommendations of the TG-25 report, which specifically say that it be used for relative depth dose determinations; and~2! the TG-21 protocol be used for calibration. The choice of phantom and chamber should be made in order to minimize the magnitude of the required correction factor, thus decreasing the uncertainty in the dose determination. The RPC will continue to use TG-21 for calibration with a 2 mm shift to the effective point of measurement for a Farmertype chamber in a water phantom for all electron energies. This may introduce discrepancies of up to 1% for low-energy electrons~5-10 MeV! when compared with the TG-21 protocol with no shift correction for measurement at d max with a cylindrical chamber.
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